Literature DB >> 16957613

Focal tumor ablation: a new era in cancer therapy.

Thomas C Winter1, Paul F Laeseke, Fred T Lee.   

Abstract

This article describes an approach to image-guided tumor ablation, a major tool for cancer treatment in interventional oncology. An overview of the discipline of tumor ablation is followed by a review of the diseases affecting the liver; then, more in-depth discussion of percutaneous ethanol injection, radiofrequency ablation, cryoablation, and microwave ablation is offered. Inasmuch as ultrasound is usually the best imaging modality for applicator placement in the liver and kidney, particular attention will be given to the merits and techniques of this guidance method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16957613     DOI: 10.1097/01.ruq.0000232614.79547.b6

Source DB:  PubMed          Journal:  Ultrasound Q        ISSN: 0894-8771            Impact factor:   1.657


  5 in total

1.  Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue.

Authors:  A Andreano; Yu Huang; M Franca Meloni; Fred T Lee; Christopher Brace
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

2.  Analysis of tissue changes, measurement system effects, and motion artifacts in echo decorrelation imaging.

Authors:  Fong Ming Hooi; Anna Nagle; Swetha Subramanian; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2015-02       Impact factor: 1.840

3.  Theoretical modeling for hepatic microwave ablation.

Authors:  Punit Prakash
Journal:  Open Biomed Eng J       Date:  2010-02-04

4.  Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.

Authors:  Maria Franca Meloni; Anita Andreano; Paul F Laeseke; Tito Livraghi; Sandro Sironi; Fred T Lee
Journal:  Radiology       Date:  2009-08-25       Impact factor: 11.105

5.  Terminology and reporting criteria for radiofrequency ablation of tumors in the scientific literature: systematic review of compliance with reporting standards.

Authors:  Tae Wook Kang; Hyunchul Rhim; Min Woo Lee; Young-sun Kim; Dongil Choi; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.